Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of scheduled meeting with Fund/Broking House/Company: Date Name of Fund/Broking House/Company City Type of meeting 21st August, 2019 Motilal Oswal Annual Investor Conference Mumbai Group / One to One Note: The schedule of the aforesaid meeting is subject to change. The changes may happen due to exigencies on the part of Fund/Broking House/Company. We request you to kindly take the same on record.
19-08-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirayu Pvt Ltd
13-08-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Fenofibrate Tablets USP, 48 mg and 145 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
13-08-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%. Please find enclosed herewith our press release. We request you to kindly take the same on record.
13-08-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirayu Pvt Ltd
12-08-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the Company has issued Duplicate Share Certificate(s) to the shareholder(s) and / or legal hier(s) of the registered shareholders on 12th August, 2019.
12-08-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the shareholder(s) of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s).
12-08-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Bimatoprost Ophthalmic Solution, 0.01%. Please find enclosed herewith our press release. We request you to kindly take the same on record.
09-08-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Alembic Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-07-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 With reference to the captioned matter, we would like to state that the 9th Annual General Meeting of the Company was held on 29th July, 2019 at 'Sanskruti', Alembic Corporate Conference Center, Opp. Pragati Sahakari Bank Limited, Alembic Colony, Vadodara - 390 003. Please find enclosed herewith: a) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. b) Scrutinizers' Report on E-voting and Poll as per the provisions of Section 108 and 109 of the Companies Act, 2013 read with Companies (Management and Administration), Rules, 2014. We request you to kindly take the same on record.
29-07-2019
Next Page
Close

Let's Open Free Demat Account